CAS No.110267-81-7,Amrubicin Suppliers

Products Categories

Pharmaceutical (54)
Organic Chemicals (8)
Others (3)
Reagent (1)

Basic Information

Molecular Structure:
CAS No.:	110267-81-7
Name:	Amrubicin
Article Data:	3

Formula:	C₂₅H₂₅NO₉
Molecular Weight:	483.475
Synonyms:	5,12-Naphthacenedione,9-acetyl-9-amino-7-[(2-deoxy-b-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-,(7S,9S)-;
Density:	1.6 g/cm³
Melting Point:	172-174 °C
Boiling Point:	717.8 °C at 760 mmHg
Flash Point:	387.9 °C
PSA:	176.61000
LogP:	1.33210

Total:62 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 110267-81-7

Specification

1. Introduction of Amrubicin
Amrubicin is one kind of Pharmaceuticals. Amrubicin systematic name is (1S,3S)-3-acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2-deoxy-β-D-erythro-pentopyranoside. Additionally, its product categories are Carbohydrates & Derivatives; Chiral Reagents; Intermediates & Fine Chemicals; Pharmaceuticals. Its Classification Code is Antineoplastic; Antineoplastic Agents. Amrubicin can soluble in Chloroform.

2. Properties of Amrubicin
Physical properties about Amrubicin are:
(1)ACD/LogP: 2.64; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 2.27; (4)ACD/LogD (pH 7.4): 2.29; (5)ACD/BCF (pH 5.5): 25.59; (6)ACD/BCF (pH 7.4): 26.47; (7)ACD/KOC (pH 5.5): 278.33; (8)ACD/KOC (pH 7.4): 287.93; (9)#H bond acceptors: 10; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 8; (12)Polar Surface Area: 109.83 Å²; (13)Index of Refraction: 1.72; (14)Molar Refractivity: 119.01 cm³; (15)Molar Volume: 301.1 cm³; (16)Polarizability: 47.17×10^-24cm³; (17)Surface Tension: 95.4 dyne/cm; (18)Density: 1.6 g/cm³; (19)Flash Point: 387.9 °C; (20)Enthalpy of Vaporization: 110.12 kJ/mol; (21)Boiling Point: 717.8 °C at 760 mmHg; (22)Vapour Pressure: 1.26E-21 mmHg at 25°C.

3. Structure Descriptors of Amrubicin
(1)SMILES: O=C2c1c(O)c5c(c(O)c1C(=O)c3ccccc23)C[C@](C(=O)C)(N)C[C@@H]5O[C@@H]4OC[C@@H](O)[C@@H](O)C4
(2)InChI: InChI=1/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1
(3)InChIKey: VJZITPJGSQKZMX-XDPRQOKABQ
(4)Std. InChI: InChI=1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1
(5)Std. InChIKey: VJZITPJGSQKZMX-XDPRQOKASA-N

4. Uses of Amrubicin
Amrubicin can be used to manufacture Antineoplastic drug. In other words, this API is successfully used in small cells lung cancer treatment (one of the most powerful anticancer agents with low cardio-toxicity) and it is also tested on other types of cancer (blood cancer, prostate cancer etc).

Amrubicin is marketed in Japan since 2002 by Sumitomo Pharmaceuticals under the brand name Calsed. Amrubicin acts by inhibiting topoisomerase II, and has been compared in clinical trials with topotecan, a Topoisomerase I inhibitor.